Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

NCT02582697 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT02582697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02582697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Lead sponsor
University of Sydney
Phase
Phase 3
Overall status
Recruiting
Start date
February 28, 2014
Completion date
December 31, 2029
Enrollment
500 (estimated)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

germ cell tumor